
Nipah virus
A bat-reservoir paramyxovirus with a case-fatality rate of 40-75% and no licensed vaccine; recurrently detected in Kerala, India, where outbreak surveillance has contained every case since 2018.
Last refreshed: 16 June 2026 · Appears in 1 active topic
Why does Nipah keep reappearing in Kozhikode, and how has Kerala contained it every time?
Timeline for Nipah virus
Kerala Nipah quiet two weeks on
Pandemics and BiosecurityConfirmed in a Kozhikode patient on 11 June with suspected bat-building exposure
Pandemics and Biosecurity: Kerala catches a Nipah case early againBackground
Nipah virus is a Paramyxovirus carried in the excretions of Pteropus fruit bats and capable of spilling into humans through contaminated food, animal contact, or healthcare settings. Kerala, India confirmed a fresh Nipah case on 11 June 2026 in Kozhikode: a 43-year-old man in critical condition on a ventilator, with suspected exposure from cleaning a bat-infested building. The Indian Council of Medical Research deployed a team, and contact tracing reached approximately 100 people, of whom 58 were healthcare workers. Three consecutive days with no new positives followed, and containment-zone restrictions were eased, indicating early containment rather than the start of a sustained chain.
Nipah is classified among the most dangerous emerging pathogens because its case-fatality rate ranges from 40 to 75 percent depending on caseload and healthcare capacity, and no licensed vaccine or broadly effective treatment exists. It is caused by an RNA virus in the Henipavirus genus of the Paramyxoviridae family, related to Hendra virus. Transmission between people occurs primarily through close contact with respiratory secretions or body fluids, which is why healthcare workers consistently represent the highest-risk secondary group. Kerala has experienced recurring Kozhikode outbreaks since a 2018 event that killed 17 of 19 confirmed cases, and the state has developed one of the most effective rapid-response systems for Nipah of any jurisdiction globally.
Nipah sits on the WHO R&D Blueprint's Paramyxovirus priority list, which coordinates medical countermeasure research for pathogens that combine pandemic potential with an absence of licensed products. Bangladesh experiences near-annual winter outbreaks via date PALM SAP consumption, and the Bangladesh lineage has a higher person-to-person transmission rate than the Kerala/Malaysia lineages. The Kerala pattern since 2018 demonstrates that outbreak containment is achievable through tracing and isolation alone, but each recurrence is a reminder that the margin between contained and epidemic rests entirely on speed of response.